U.S. Markets open in 1 hr 37 mins

Haemonetics Corporation (HAE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
74.68-42.29 (-36.15%)
At close: 4:00PM EDT

74.53 -0.15 (-0.20%)
Pre-Market: 7:46AM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close116.97
Open91.94
Bid74.85 x 800
Ask74.79 x 1000
Day's Range74.10 - 93.74
52 Week Range74.10 - 142.11
Volume6,616,385
Avg. Volume398,638
Market Cap3.795B
Beta (5Y Monthly)0.50
PE Ratio (TTM)35.23
EPS (TTM)2.12
Earnings DateMay 03, 2021 - May 07, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est140.83
  • TheStreet.com

    Haemonetics Slumps as CSL Plasma Declines to Renew a Supply Pact

    About 12% of Haemonetics 2020 revenue came from a contract with CSL Plasma. CSL declined to renew the accord.

  • Haemonetics Provides Update On U.S. Plasma Business
    PR Newswire

    Haemonetics Provides Update On U.S. Plasma Business

    Haemonetics Corporation (NYSE: HAE) ("Haemonetics" or the "Company"), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that CSL Plasma, Ltd. ("CSL") has informed Haemonetics of its intent not to renew its Supply Agreement with Haemonetics for the use of PCS2® Plasma Collection System devices and the purchase of disposable plasmapheresis kits in the U.S. following the expiration of the current term in June 2022. Haemonetics was informed that the decision was based on changes in CSL's internal strategy and was not related to product or service quality.

  • The Haemonetics (NYSE:HAE) Share Price Has Gained 233%, So Why Not Pay It Some Attention?
    Simply Wall St.

    The Haemonetics (NYSE:HAE) Share Price Has Gained 233%, So Why Not Pay It Some Attention?

    The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, a...